All Stories

  1. Warfarin Treatment Is Associated to Increased Internal Carotid Artery Calcification

    Article • Frontiers in Neurology, July 2021, Frontiers

    Mikko I. Mäyränpää

  2. SOX9 has distinct roles in the formation and progression of different non‐small cell lung cancer histotypes

    Article • The Journal of Pathology, June 2021, Wiley

    Mikko I. Mäyränpää

  3. Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25‐Year Nationwide Cohorts

    Article • Journal of the American Heart Association, March 2021, Wolters Kluwer Health

    Mikko I. Mäyränpää

  4. Cardiovascular disease risk factors induce mesenchymal features and senescence in mouse cardiac endothelial cells

    Article • eLife, March 2021, eLife

    Mikko I. Mäyränpää

  5. Artificial intelligence identifies inflammation and confirms fibroblast foci as prognostic tissue biomarkers in idiopathic pulmonary fibrosis

    Article • Human Pathology, January 2021, Elsevier

    Mikko I. Mäyränpää

  6. Osteoid Metaplasia in Femoral Artery Plaques Is Associated With the Clinical Severity of Lower Extremity Artery Disease in Men

    Article • Frontiers in Cardiovascular Medicine, December 2020, Frontiers

    Mikko I. Mäyränpää

  7. Predictive Factors for Pre-operative Recurrence of Cerebrovascular Symptoms in Symptomatic Carotid Stenosis

    Article • European Journal of Vascular and Endovascular Surgery, December 2020, Elsevier

    Mikko I. Mäyränpää

  8. Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses

    Article • Clinical Lung Cancer, November 2020, Elsevier

    Mikko I. Mäyränpää

  9. Idiopathic giant cell myocarditis or cardiac sarcoidosis? A retrospective audit of a nationwide case series

    Article • ESC Heart Failure, April 2020, Wiley

    Mikko I. Mäyränpää

  10. Folate Receptor β–Targeted PET Imaging of Macrophages in Autoimmune Myocarditis

    Article • Journal of Nuclear Medicine, April 2020, Society of Nuclear Medicine

    Mikko I. Mäyränpää

  11. Histopathological features of epithelioid malignant pleural mesotheliomas in patients with extended survival

    Article • Human Pathology, April 2020, Elsevier

    Mikko I. Mäyränpää

  12. Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras-Mutant Lung Cancers

    Article • Molecular Cancer Therapeutics, July 2019, American Association for Cancer Research (AACR)

    Mikko I. Mäyränpää

  13. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries

    Article • European Heart Journal, June 2019, Oxford University Press (OUP)

    Mikko I. Mäyränpää

  14. Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block

    Article • Circulation Arrhythmia and Electrophysiology, August 2018, Wolters Kluwer Health

    Mikko I. Mäyränpää

  15. Morphology and histology of silent and symptom-causing atherosclerotic carotid plaques – Rationale and design of the Helsinki Carotid Endarterectomy Study 2 (the HeCES2)

    Article • Annals of Medicine, July 2018, Taylor & Francis

    Perttu Lindsberg, Sonja Kasari, Mikko I. Mäyränpää

  16. Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras -driven lung tumours

    Article • The Journal of Pathology, April 2018, Wiley

    Mikko I. Mäyränpää

  17. Human mast cell neutral proteases generate modified LDL particles with increased proteoglycan binding

    Article • Atherosclerosis, April 2018, Elsevier

    Dr Katariina Öörni, Mikko I. Mäyränpää

  18. TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma

    Article • The Journal of Pathology, May 2017, Wiley

    Mikko I. Mäyränpää

  19. Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1

    Article • Cell Reports, January 2017, Elsevier

    Mikko I. Mäyränpää

  20. p38δ MAPKHighlights

    Article • Arteriosclerosis Thrombosis and Vascular Biology, July 2016, Wolters Kluwer Health

    Dr Katariina Öörni, Mikko I. Mäyränpää

  21. Imatinib treatment attenuates growth and inflammation of angiotensin II induced abdominal aortic aneurysm

    Article • Atherosclerosis, June 2016, Elsevier

    Mikko I. Mäyränpää

  22. Novel 6p21.3 Risk Haplotype Predisposes to Acute Coronary Syndrome

    Article • Circulation Cardiovascular Genetics, February 2016, Wolters Kluwer Health

    Mikko I. Mäyränpää

  23. TRIF adaptor signaling is important in abdominal aortic aneurysm formation

    Article • Atherosclerosis, August 2015, Elsevier

    Mikko I. Mäyränpää

  24. Lipoprotein-associated lipids accumulate in distinctive domains in atherosclerotic arteries.

    Article • American Journal Of Pathology, May 2015, Elsevier

    Dr Katariina Öörni, Dr Satu Lehti, Mikko I. Mäyränpää

  25. Low-Expression Variant of Fatty Acid–Binding Protein 4 Favors Reduced Manifestations of Atherosclerotic Disease and Increased Plaque Stability

    Article • Circulation Cardiovascular Genetics, October 2014, Wolters Kluwer Health

    Mikko I. Mäyränpää

  26. VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart

    Article • EMBO Molecular Medicine, January 2014, EMBO

    Mikko I. Mäyränpää, Riikka Kivelä

  27. Osbpl8 Deficiency in Mouse Causes an Elevation of High-Density Lipoproteins and Gender-Specific Alterations of Lipid Metabolism

    Article • PLoS ONE, March 2013, PLOS

    Mikko I. Mäyränpää

  28. Imatinib mesylate alleviates diarrhea in a mouse model of intestinal allergy

    Article • Neurogastroenterology & Motility, June 2012, Wiley

    Mikko I. Mäyränpää

  29. Serine protease inhibitor A3 in atherosclerosis and aneurysm disease

    Article • International Journal of Molecular Medicine, May 2012, Spandidos Publications

    Mikko I. Mäyränpää

  30. Mast Cells

    Article • Arteriosclerosis Thrombosis and Vascular Biology, April 2011, Wolters Kluwer Health

    Mikko I. Mäyränpää

  31. Increased expression of leukotriene C4synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm

    Article • Proceedings of the National Academy of Sciences, November 2010, Proceedings of the National Academy of Sciences

    Mikko I. Mäyränpää

  32. OSBP-related protein 11 (ORP11) dimerizes with ORP9 and localizes at the Golgi–late endosome interface

    Article • Experimental Cell Research, November 2010, Elsevier

    Mikko I. Mäyränpää

  33. Vascular Endothelial Growth Factor–Secreting Mast Cells and Myofibroblasts

    Article • Arteriosclerosis Thrombosis and Vascular Biology, June 2010, Wolters Kluwer Health

    Mikko I. Mäyränpää

  34. Dilated cardiomyopathy alters the expression patterns of CAR and other adenoviral receptors in human heart

    Article • Histochemistry and Cell Biology, December 2009, Springer Science + Business Media

    Mikko I. Mäyränpää

  35. Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms

    Article • Journal of Vascular Surgery, August 2009, Elsevier

    Mikko I. Mäyränpää

  36. Rab8 Regulates ABCA1 Cell Surface Expression and Facilitates Cholesterol Efflux in Primary Human Macrophages

    Article • Arteriosclerosis Thrombosis and Vascular Biology, June 2009, Wolters Kluwer Health

    Mikko I. Mäyränpää

  37. ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model

    Article • BMC Cardiovascular Disorders, March 2009, Springer Science + Business Media

    Mikko I. Mäyränpää

  38. Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves

    Article • Journal of Lipid Research, July 2008, Elsevier

    Mikko I. Mäyränpää

  39. The R-Ras interaction partner ORP3 regulates cell adhesion

    Article • Journal of Cell Science, February 2008, The Company of Biologists

    Sanna Lehtonen, Mikko I. Mäyränpää

  40. OSBP-related Protein 8 (ORP8) Suppresses ABCA1 Expression and Cholesterol Efflux from Macrophages

    Article • Journal of Biological Chemistry, January 2008, Elsevier

    Mikko I. Mäyränpää

  41. Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques

    Article • Atherosclerosis, November 2007, Elsevier

    Mikko I. Mäyränpää

  42. Bone densitometry in the diagnosis of vertebral fractures in children: Accuracy of vertebral fracture assessment

    Article • Bone, September 2007, Elsevier

    Mikko I. Mäyränpää

  43. Mast cells in vulnerable atherosclerotic plaques – a view to a kill

    Article • Journal of Cellular and Molecular Medicine, July 2007, Wiley

    Mikko I. Mäyränpää

  44. Complement regulation in human atherosclerotic coronary lesions

    Article • Atherosclerosis, May 2007, Elsevier

    Mikko I. Mäyränpää

  45. Improved Identification of Endothelial Erosion by Simultaneous Detection of Endothelial Cells (CD31/CD34) and Platelets (CD42b)

    Article • Endothelium, January 2007, Taylor & Francis

    Mikko I. Mäyränpää

  46. Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion

    Article • Coronary Artery Disease, November 2006, Wolters Kluwer Health

    Mikko I. Mäyränpää

  47. Endothelial Apoptosis Does Not Determine Symptom Status in Carotid Artery Disease

    Article • Cerebrovascular Diseases, September 2006, Karger Publishers

    Mikko I. Mäyränpää

  48. Increased Expression of Elastolytic Cathepsins S, K, and V and Their Inhibitor Cystatin C in Stenotic Aortic Valves

    Article • Arteriosclerosis Thrombosis and Vascular Biology, August 2006, Wolters Kluwer Health

    Dr Katariina Öörni, Mikko I. Mäyränpää

  49. Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology

    Article • Histochemistry and Cell Biology, March 2006, Springer Science + Business Media

    Annele Sainio, Mikko I. Mäyränpää

  50. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves

    Article • European Heart Journal, January 2006, European Society of Cardiology

    Mikko I. Mäyränpää

  51. Increased expression of bradykinin type-1 receptors in endothelium of intramyocardial coronary vessels in human failing hearts

    Article • AJP Heart and Circulatory Physiology, May 2005, American Physiological Society

    Mikko I. Mäyränpää

  52. Induction of local angiotensin II-producing systems in stenotic aortic valves

    Article • Journal of the American College of Cardiology, November 2004, Elsevier

    Mikko I. Mäyränpää

  53. Cysteine Protease Cathepsin F Is Expressed in Human Atherosclerotic Lesions, Is Secreted by Cultured Macrophages, and Modifies Low Density Lipoprotein Particlesin Vitro

    Article • Journal of Biological Chemistry, June 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Katariina Öörni, Mikko I. Mäyränpää

  54. Arterial endothelial denudation by intraluminal use of papaverine–NaCl solution in coronary bypass surgery

    Article • European Journal of Cardio-Thoracic Surgery, April 2004, Oxford University Press (OUP)

    Mikko I. Mäyränpää

  55. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure

    Article • Biochemical and Biophysical Research Communications, August 2003, Elsevier

    Mikko I. Mäyränpää

  56. Down-regulation of cardioprotective bradykinin type-2 receptors in the left ventricle of patients with end-stage heart failure

    Article • Journal of the American College of Cardiology, July 2002, Elsevier

    Mikko I. Mäyränpää